Theleme Partners LLP MRNA Holdings History

Number of Shares
7.24 Mil
Current Holdings Value*
$205.32 Mil
% of Portfolio
16.14%
Total Estimate Gain
$403.26 Mil
% of Total Estimate Gain
39.41%

Theleme Partners LLP's Moderna Inc Holding Summary

As of 2025-03-31, Theleme Partners LLP held 7.24 Mil shares of Moderna Inc(MRNA), totaling $205.32 Mil. This investment constitutes 16.14% of their stock portfolio, and Theleme Partners LLP now holds 1.87% of the outstanding Moderna Inc(MRNA) stock.

The initial trade took place in 2019Q1. And since then Theleme Partners LLP has made 14 purchases of MRNA, at an average price of $73.84, for a total of 13.86 Mil shares. In addition, there have been 10 sales at an average price of $185.90 for 6.61 Mil shares. Based on historical transaction data and MRNA's current price of $27.16, Theleme Partners LLP's estimated gain on his MRNA holdings is $403.26 Mil, reflecting a 39.41% gain to date.

Theleme Partners LLP MRNA ($27.16) Holding Chart

Theleme Partners LLP MRNA ($27.16) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1